News

BioM's articles and press releases about the Bavarian biotechnology sector


ITM Opens World's Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer

ITM Iso­tope Tech­no­lo­gies Mu­nich SE (ITM) opened its new pro­duc­tion fa­cil­ity for Lute­tium-177 for tar­geted ra­di­o­nuc­lide…

First single cell atlas of the lung published

Helm­holtz Mu­nich sci­ent­ists, to­geth­er with an in­ter­na­tion­al team of re­search­ers, have de­veloped the "Human Lung Cell Atlas".…

ITM raises record sum of 255 million euros

Garch­ing-based ITM has an­nounced one of the largest private in­vest­ment rounds in European bi­o­tech­no­logy to date.  With the sum of…

BioM info day "Lunch & Learn: How we support your biotech idea!" informs students and entrepreneur-in-spe about programs and support for founders

In the scope of the “Bay­erischen Gründung­stage”, BioM in­vited to an info day in the rooms of the start-up in­cub­at­or-to-be "Mu­nich…

Biotech start-ups looking for capital at BioM BioAngels Pitch Day

Zehn aus­gewählte Gründung­steams zeigten das große Poten­tial der bay­erischen Start-up-Szene mit ihren Pitches vor Ven­ture Cap­it­al…

m4 Award winner smartbax completes seed funding of EUR 1.2 million to develop innovative antibiotics against multi-resistant bacteria

Mu­nich-based bi­otech com­pany and m4 Award win­ner smart­bax, which de­vel­ops next-gen­er­a­tion an­ti­bi­ot­ics, has closed a EUR 1.2…

BioMan4R2 launches its Call for proposals!

SMEs from the bio­man­u­fac­tur­ing and med­ic­al tech­no­logy sec­tors are eli­gible to apply for up to 60,000 Euro under the BioMan4R2…

Sandoz invests 25 million euros and expands Holzkirchen into a Biopharma Technical Development hub

San­doz, man­u­fac­turer of gen­er­ic and bi­osim­il­ar medi­cines, makes an in­vest­ment of ap­prox­im­ately EUR 25 mil­lion in its site in…

INCATE catalyzes critical growth stage at m4 Award winner Invitris

INCATE has se­lec­ted m4 Award 2021 win­ner In­vit­ris as the first ven­ture to re­ceive 250,000 Euro in “Stage II Fund­ing” that will allow…

Newsletter

Subscribe

Archive



Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager